Patents by Inventor Michael Longo
Michael Longo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12232730Abstract: A method of implanting and securing an implantable flow connector in a body of a patient for providing communication of a first space within the body of the patient with a second space within the body of the patient. The method includes providing a flow connector having a lumen having a first orifice and a second orifice, inserting a retention device into the first space within the body, subsequently inserting the flow connector through an opening in the retention device so the second portion of the flow connector extends into the first space within the body and placing the second space within the body over the retention device.Type: GrantFiled: December 23, 2020Date of Patent: February 25, 2025Assignee: TVA Medical, Inc.Inventors: Michael Paris, Adam Dakin, Todd Polk, Mahesh Krishnamoorthy, Jin Park, Michael Longo, Peter Hinchliffe
-
Patent number: 11938046Abstract: A medical implant may include a structural member and a radiopaque marker. The structural member may include a first surface, a second surface disposed opposite the first surface, an opening extending from the first surface to the second surface and defining a central axis, and a plurality of barbs extending into the opening toward the central axis. The barbs may be spaced apart from one another and spaced apart from each of the first surface and the second surface. The radiopaque marker may be disposed within the opening.Type: GrantFiled: May 19, 2022Date of Patent: March 26, 2024Assignee: VESPER MEDICAL, INC.Inventors: Michael Longo, Christopher Turek, Timothy O'Neil, Daniel Alexander
-
Patent number: 11660218Abstract: A delivery device can provide sequential delivery of a plurality of intraluminal devices held in a compressed state on the delivery device. Delivery platforms on the delivery device can hold an intraluminal device in a compressed position and be positioned between pusher bands that may also be radiopaque markers. A post deployment dilation device can be included. The post deployment dilation device can be a plurality of expansion filaments, a bellows, or a balloon. An intravascular device deployment method can include allowing a self-expanding intravascular device to expand, aligning the post deployment dilation device under the intravascular device, and causing the post deployment dilation device to expand radially to push outward on the intravascular device.Type: GrantFiled: July 24, 2018Date of Patent: May 30, 2023Assignee: INTACT VASCULAR, INC.Inventors: Michael Longo, Michael Horzewski
-
Publication number: 20220304834Abstract: A medical implant may include a structural member and a radiopaque marker. The structural member may include a first surface, a second surface disposed opposite the first surface, an opening extending from the first surface to the second surface and defining a central axis, and a plurality of barbs extending into the opening toward the central axis. The barbs may be spaced apart from one another and spaced apart from each of the first surface and the second surface. The radiopaque marker may be disposed within the opening.Type: ApplicationFiled: May 19, 2022Publication date: September 29, 2022Inventors: Michael Longo, Christopher Turek, Timothy O'Neil, Daniel Alexander
-
Patent number: 11376140Abstract: A medical implant may include a structural member and a radiopaque marker. The structural member may include a first surface, a second surface disposed opposite the first surface, an opening extending from the first surface to the second surface and defining a central axis, and a plurality of barbs extending into the opening toward the central axis. The barbs may be spaced apart from one another and spaced apart from each of the first surface and the second surface. The radiopaque marker may be disposed within the opening.Type: GrantFiled: September 15, 2021Date of Patent: July 5, 2022Assignee: Vesper Medical, Inc.Inventors: Michael Longo, Christopher Turek, Timothy O'Neil, Daniel Alexander
-
Patent number: 11304836Abstract: A delivery device can provide sequential delivery of a plurality of intraluminal devices or tacks held in a compressed state on the delivery device. Delivery platforms on the delivery device can hold a tack in a compressed position and be positioned between annular pusher bands that may also be radiopaque markers. The annular pusher bands can be made of wire or sections of material to increase flexibility while remaining radiopacity. A post deployment dilation device can be included. The post deployment dilation device can be a plurality of expansion filaments, a bellows, or a balloon. A tack deployment method can include allowing a self-expanding tack to expand, aligning the post deployment dilation device under the tack, and causing the post deployment dilation device to expand radial to push outward on the tack.Type: GrantFiled: April 1, 2019Date of Patent: April 19, 2022Assignee: INTACT VASCULAR, INC.Inventor: Michael Longo
-
Patent number: 11214791Abstract: A binding agent to a target molecule, or method or kit where the binding agent is selected from a library where each variant has a circular permutation of the FHA domain where the rearrange does not substantially disrupt the FHA domain's beta-sheet scaffold or increase the stability of the beta-sheet scaffold. The randomized regions of the FHA domain include the endogenous binding interface the FHA domain, the region opposite of the endogenous binding interface, and the circular permutation region.Type: GrantFiled: April 25, 2017Date of Patent: January 4, 2022Inventors: Rajika Perera, Michael Longo
-
Patent number: 11208444Abstract: The invention is the products and methods associated with purifying overexpressed recombinant recombinases from a host cell line resulting in an un-tagged protein of interest without any additional, non-native amino acids. The invention employs at least one DNA vector that co-expresses a tagged fusion protein and the recombinase protein with the recombinase protein having an affinity for binding to the tagged fusion protein. Isolation methods of the recombinase protein include the targeting of the tagged fusion protein.Type: GrantFiled: February 28, 2020Date of Patent: December 28, 2021Assignee: Idea Seed, LLC.Inventor: Michael Longo
-
Patent number: 11180284Abstract: A multi-compartment container system includes a plurality of compartments. Each compartment includes a cup portion comprising a volume adapted to hold a food or liquid, and a frame portion joined to the cup portion. The frame portion surrounds a top portion or edge of the cup portion, and includes a connector element disposed on a side of the frame and one or more first mating elements. The compartment also includes a lid having one or more second mating elements adapted to engage with the one or more first mating elements of the frame to form a seal, and a chamber adapted to hold a utensil. The connector element of the frame is joined to an adjacent connector element of an adjacent frame of an adjacent compartment. The cup portion includes a first section and a second section, and the cup portion is adapted to move between an expanded state in which no part of the second section is inside the first section and a collapsed state in which at least a portion of the second section is inside the first section.Type: GrantFiled: August 23, 2019Date of Patent: November 23, 2021Inventor: Stephen Michael Longo
-
Patent number: 11147694Abstract: A medical implant may include a structural member and a radiopaque marker. The structural member may include a first surface, a second surface disposed opposite the first surface, an opening extending from the first surface to the second surface and defining a central axis, and a plurality of barbs extending into the opening toward the central axis. The barbs may be spaced apart from one another and spaced apart from each of the first surface and the second surface. The radiopaque marker may be disposed within the opening.Type: GrantFiled: March 26, 2021Date of Patent: October 19, 2021Assignee: VESPER MEDICAL, INC.Inventors: Michael Longo, Christopher Turek, Timothy O'Neil, Daniel Alexander
-
Publication number: 20210177420Abstract: A method of implanting and securing an implantable flow connector in a body of a patient for providing communication of a first space within the body of the patient with a second space within the body of the patient. The method includes providing a flow connector having a lumen having a first orifice and a second orifice, inserting a retention device into the first space within the body, subsequently inserting the flow connector through an opening in the retention device so the second portion of the flow connector extends into the first space within the body and placing the second space within the body over the retention device.Type: ApplicationFiled: December 23, 2020Publication date: June 17, 2021Applicant: TVA Medical, Inc.Inventors: Michael Paris, Adam Dakin, Todd Polk, Mahesh Krishnamoorthy, Jin Park, Michael Longo, Peter Hinchliffe
-
Patent number: 10993824Abstract: A delivery device can provide sequential delivery of a plurality of intraluminal devices or tacks held in a compressed state on the delivery device. Delivery platforms on the delivery device can hold a tack in a compressed position and be positioned between annular pusher bands that may also be radiopaque markers. The annular pusher bands can be made of wire or sections of material to increase flexibility while remaining radiopacity. A post deployment dilation device can be included. The post deployment dilation device can be a plurality of expansion filaments, a bellows, or a balloon. A tack deployment method can include allowing a self-expanding tack to expand, aligning the post deployment dilation device under the tack, and causing the post deployment dilation device to expand radial to push outward on the tack.Type: GrantFiled: December 29, 2016Date of Patent: May 4, 2021Assignee: INTACT VASCULAR, INC.Inventor: Michael Longo
-
Patent number: 10987106Abstract: A method of implanting and securing an implantable flow connector in a body of a patient for providing communication of a first space within the body of the patient with a second space within the body of the patient. The method includes providing a flow connector having a lumen having a first orifice and a second orifice, inserting a retention device into the first space within the body, subsequently inserting the flow connector through an opening in the retention device so the second portion of the flow connector extends into the first space within the body and placing the second space within the body over the retention device.Type: GrantFiled: February 6, 2016Date of Patent: April 27, 2021Assignee: TVA Medical, Inc.Inventors: Michael Paris, Adam Dakin, Todd Polk, Mahesh Krishnamoorthy, Jin Park, Michael Longo, Peter W. J. Hinchliffe
-
Patent number: 10898356Abstract: A delivery device can provide sequential delivery of a plurality of intraluminal devices or tacks held in a compressed state on the delivery device. Delivery platforms on the delivery device can hold a tack in a compressed position and have a unique shape, such as a non-constant outer diameter, an hourglass shape, a tapered proximal half, ridges, dimples, etc. This unique shape can be positioned between annular pusher bands that may also be radiopaque markers. In some embodiments, the unique shape is provided by a sleeve of flexible material with the unique shape surrounding a harder inner shaft. Further, the annular pusher bands can be made of wire or sections of material to increase flexibility while remaining radiopacity. A tack deployment method can include alignment of radiopaque markers on the outer sheath and the tack to be deployed prior to deployment.Type: GrantFiled: June 27, 2016Date of Patent: January 26, 2021Assignee: Intact Vascular, Inc.Inventors: Michael Longo, Douglas Evans, William James Harrison
-
Patent number: 10870926Abstract: A general method and recombinant nucleic acid sequences, by means which the method selects a recombinant protein containing an FHA domain for binding a target molecule from a library proteins with a high-throughput method of creating protein variations within the FHA domain in non-conserved or non-structural sequences of the FHA scaffold, and the library may also be in the form of a phagemid or phage library wherein the ALP nucleic acid sequence is inserted into a vector capable of allowing the vector and expressed ALP protein from being virally packaged, and the recombinant nucleic acid sequences which are randomly mutated at varying non-conserved or non-structural FHA domain sequences.Type: GrantFiled: June 18, 2019Date of Patent: December 22, 2020Assignee: IDEA ORCHARD, LLCInventors: Michael Longo, Rajika Perera
-
Publication number: 20200315827Abstract: A delivery device can include several different features including, at least: a shuttle and trigger retraction of an outer sheath; an interlock device to prevent actuation of the trigger; a retraction override switch and lock; and an inner shaft adjuster to ensure correct alignment of the inner shaft and the outer sheath prior to device deployment. The inner shaft adjuster may include, at least: a proximal portion of the handle housing having slots therethrough: pins operatively fixed to the inner shaft and extending through and slidable within the slots: and a cap having an inner helical groove that mates with the pins. Rotation of the cap may push the pins and the inner shaft in a proximal-distal direction. The cap may have a distal lip configured to accept a proximal extension of the interlock and retain it in a locked position until the inner shaft has been adjusted or moved.Type: ApplicationFiled: March 17, 2020Publication date: October 8, 2020Inventors: Michael Longo, Michael Dotsey
-
Publication number: 20200291080Abstract: The invention is the products and methods associated with purifying overexpressed recombinant recombinases from a host cell line resulting in an un-tagged protein of interest without any additional, non-native amino acids. The invention employs at least one DNA vector that co-expresses a tagged fusion protein and the recomibinase protein with the recombinase protein having an affinity for binding to the the tagged fusion protein. Isolation methods of the recominbase protein include the targeting of the tagged fusion protein.Type: ApplicationFiled: February 28, 2020Publication date: September 17, 2020Applicant: Idea Seed, LLCInventor: Michael Longo
-
Publication number: 20200277105Abstract: A multi-compartment container system includes a plurality of compartments. Each compartment includes a cup portion comprising a volume adapted to hold a food or liquid, and a frame portion joined to the cup portion. The frame portion surrounds a top portion or edge of the cup portion, and includes a connector element disposed on a side of the frame and one or more first mating elements. The compartment also includes a lid having one or more second mating elements adapted to engage with the one or more first mating elements of the frame to form a seal, and a chamber adapted to hold a utensil. The connector element of the frame is joined to an adjacent connector element of an adjacent frame of an adjacent compartment. The cup portion includes a first section and a second section, and the cup portion is adapted to move between an expanded state in which no part of the second section is inside the first section and a collapsed state in which at least a portion of the second section is inside the first section.Type: ApplicationFiled: August 23, 2019Publication date: September 3, 2020Inventor: Stephen Michael Longo
-
Publication number: 20200155332Abstract: A delivery device can provide sequential delivery of a plurality of intraluminal devices held in a compressed state on the delivery device. Delivery platforms on the delivery device can hold an intraluminal device in a compressed position and be positioned between pusher bands that may also be radiopaque markers. A post deployment dilation device can be included. The post deployment dilation device can be a plurality of expansion filaments, a bellows, or a balloon. An intravascular device deployment method can include allowing a self-expanding intravascular device to expand, aligning the post deployment dilation device under the intravascular device, and causing the post deployment dilation device to expand radially to push outward on the intravascular device.Type: ApplicationFiled: July 24, 2018Publication date: May 21, 2020Inventors: Michael Longo, Michael Horzewski
-
Patent number: 10610392Abstract: A delivery device can include several different features including, at least: a shuttle and trigger retraction of an outer sheath; an interlock device to prevent actuation of the trigger; a retraction override switch and lock; and an inner shaft adjuster to ensure correct alignment of the inner shaft and the outer sheath prior to device deployment. The inner shaft adjuster may include, at least: a proximal portion of the handle housing having slots therethrough: pins operatively fixed to the inner shaft and extending through and slidable within the slots: and a cap having an inner helical groove that mates with the pins. Rotation of the cap may push the pins and the inner shaft in a proximal-distal direction. The cap may have a distal lip configured to accept a proximal extension of the interlock and retain it in a locked position until the inner shaft has been adjusted or moved.Type: GrantFiled: January 25, 2017Date of Patent: April 7, 2020Assignee: Intact Vascular, Inc.Inventors: Michael Longo, Michael Dotsey